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Abstract
Aim: To evaluate the efficacy of metacognitive group training in reducing psychotic 
symptoms and improving cognitive insight and functions in people with schizophrenia.
Design: Randomized controlled trial. It was carried out between July 2019 -February 
2020.
Methods: Fifty-six patients with schizophrenia were enrolled and randomly as-
signed to either a control group (N = 29) or a metacognitive training group (N = 27). 
Blinded assessments were made at baseline, 1-week post-treatment and at follow-up 
3 months after treatment. The primary outcome measure was psychotic symptoms 
based on the Psychotic Symptom Rating Scales (PSYRATS). Secondary outcomes 
were assessed by the Beck Cognitive Insight Scale (BCIS), the Personal and Social 
Performance (PSP) scale and the World Health Organization Disability Assessment 
Schedule (WHODAS).
Results: Completion at follow-up was high (92.86%). The intention-to-treat analy-
ses demonstrated that patients in the metacognitive training group had significantly 
greater improvements of the Psychotic Symptom Rating Scales delusion score and 
total score and the Personal and Social Performance Scale, after 3 months, compared 
with the control group. The effect size was medium to large. The intention-to-treat 
analyses also demonstrated that patients in the metacognitive training group had 
significantly greater reductions of the Psychotic Symptom Rating Scales hallucination 
score and Beck Cognitive Insight Scale self-certainty score post-treatment, compared 
with the control group. The effect size was medium to large.
Conclusion: The metacognitive training administered by psychiatric and mental 
health nurses was effective in ameliorating delusions and social functioning over time 
and it immediately reduced hallucinations post-treatment.
Impact: Metacognitive training for treating psychosis in patients with schizophrenia 
is efficacious and administration is clinically feasible in the Portuguese context.
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1  | INTRODUC TION
Schizophrenia is a complex and severe mental disorder (Lambert 
et al., 2019) and persistent psychotic symptoms represent a major 
challenge for patient care (Favrod et al., 2014). Metacognitive 
training (MCT) for psychosis is a variant of cognitive-behavioural 
therapy (CBT), but it is particularly targeted at reducing cognitive 
biases (Moritz & Woodward, 2007). MCT has been applied in many 
countries and is usually complementary to psychopharmacological 
intervention. The immediate effect of MCT in reducing delusions in 
patients is well-established (Eichner & Berna, 2016; Liu et al., 2018), 
but its long-term effects over time are less clear.
Moreover, as cultural context seems to influence the effects 
of MCT (Liu et al., 2018), more studies are needed to evaluate its 
efficacy across different cultures. We believe that MCT can be im-
portant for treating many factors associated with the symptoms of 
schizophrenia, since the treatment aims to change the meta-struc-
ture of thinking and judgement. This study addresses the impact of 
MCT, in a Portuguese population, on psychotic symptoms, cognitive 
insight and functioning in schizophrenia. Most prior studies on MCT 
involved psychologists as trainers. However, the training can also be 
performed by nurses and occupational therapists with experience 
in treating and communicating with patients with schizophrenia. To 
explore whether positive effects can also be achieved by non-ac-
ademic staff, for this study, mental health nurses administered the 
training.
1.1 | Background
Psychiatric disorders are one of the major enigmas for health profes-
sionals. Laboratory tests to confirm the presence of a severe mental 
disorder do not exist, which poses a challenge to psychiatric nurses 
in clinical practice. Instead, diagnostic assessment usually relies on 
observation, verbal and non-verbal communication, as well as on the 
use of questionnaires. The therapeutic relationship represents the 
key element of the entire care process. Lopes (2018) considers that 
nurses should evaluate the impact of symptoms of mental disorders 
on self-care, taking into consideration the family and community re-
lationships of the patient. In Portugal, after obtaining a general nurs-
ing degree, nurses can choose to specialize in one of the existing 
areas to try to obtain a master's degree that includes a theoretical 
component and a clinical internship in the area of specialization; and 
one of these specialties is mental health and psychiatric nursing. The 
specific skills acquired are regulated by the Order of Nurses (Ordem 
dos Enfermeiros, 2018, p. 21427); a properly trained nurse has the 
following characteristics that describe his or her relationship with 
the patient:
“a) Has good knowledge and awareness of himself as a person 
and as a nurse through experiences and processes of self-knowledge 
and personal and professional development;
b) Assists in optimizing mental health throughout the patient's 
life cycle, family, groups and community;
c) Helps the patient throughout the life cycle to integrate into 
their family, groups and community and in mental health recovery by 
mobilizing the dynamics specific to each context;
d) Provides psychotherapeutic, socio-therapeutic, psychosocial 
and psycho-educational care to the patient throughout their life 
cycle and mobilizes the context and individual, group or community 
dynamics to maintain, improve and recover health.”
Psychiatric nurses increasingly play an active role in the psy-
chosocial rehabilitation of patients with schizophrenia, using their 
skills and maintaining the therapeutic relationship with the patient, 
usually as part of a multidisciplinary team (Pinho et al., 2017). In 
Portugal, there are specific services which aim to provide psychoso-
cial and psychoeducational interventions to help people with severe 
mental illness during their recovery process. There are two types of 
services: those where patients receive treatment during the day and 
return home to sleep and those where patients live on-site until they 
are able to be integrated back into the community. In both types, 
treatment is administered by a multidisciplinary team of nurses, psy-
chiatrists, psychologists, occupational therapists and social workers.
Schizophrenia is a major cause of disability worldwide (Charlson 
et al., 2018). The Diagnostic and Statistical Manual of Mental 
Disorders (5th edition) defines the presence of at least two of the 
following symptoms as criteria for schizophrenia: delusion, hallu-
cination, disorganized speech, grossly disorganized or catatonic 
behaviour and negative symptoms. At least one of these symp-
toms should be among the first three listed (American Psychiatric 
Association, 2014). Significant psychosocial functional impairments 
are present in many patients who are often unemployed, living in 
poverty, homeless and experiencing functional difficulties. Patients 
with schizophrenia frequently rely on support from their families 
and mental health services (Charlson et al., 2018).
Dysfunctional thought processes of patients with delusions 
cannot be corrected with medication (Liu et al., 2018). The use of 
psychological interventions to treat specific underlying psychotic 
symptoms should be used as an adjunct to conventional approaches 
Trial Registration Number: ClinicalTrials.gov ID NCT03891186.
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(So et al., 2015). MCT was developed by Moritz and collaborators in 
2007 and has been studied in several countries. It is a therapeutic 
program that aims to prevent and reduce delusions by modifying the 
specific cognitive biases of psychosis; particularly, jumping to con-
clusions and exhibiting overconfidence in false judgments (Eichner 
& Berna, 2016; Moritz et al., 2014). The Australian Psychiatric 
Association, the German Psychiatric Association and the German 
Psychological Association now recommend MCT for the treatment 
of psychotic disorders (Moritz & Lysaker, 2018).
MCT focuses on metacognitive experience (e.g. specific cogni-
tive biases of the psychosis that the patient is not necessarily con-
sciously aware of that are made explicit and challenging; Moritz & 
Lysaker, 2018). Many patients with psychosis have a low awareness 
of these biases (Moritz et al., 2016) and MCT aims to improve meta-
cognitive awareness of these cognitive biases (Moritz et al., 2014). 
MCT group therapy avoids addressing issues related to personal 
delusions, leaving these issues to be treated by individual therapy. 
Thus, patients do not need to talk about their experiences unless 
they want to share them with the group (Moritz & Lysaker, 2018).
MCT also aims to raise cognitive insight, the concept of which 
was initially developed by Beck in 2004 and is important for treating 
schizophrenia. It encompasses the capacity of patients to reflect on 
their distorted beliefs and interpretations and helps them respond to 
corrective feedback based on a metacognitive approach. Cognitive 
insight, according to Beck, involves self-reflection and self-certainty. 
Improved cognitive insight in schizophrenia may reduce delusions 
(Riggs et al., 2012) and training can help patients accept their diag-
noses (Moritz et al., 2017).
MCT applied to patients with psychosis has shown favourable 
results in reducing delusions (Eichner & Berna, 2016; Ishikawa 
et al., 2020; Liu et al., 2018; Philipp et al., 2019). A Portuguese 
trial studied the preliminary efficacy of Metacognitive and Social 
Cognition Training (MSCT; 18 sessions) in schizophrenia, but no 
effect on positive symptoms was found, contrary to expectation 
(Rocha & Queirós, 2013).
With respect to cognitive insight and functioning, studies have 
been scarce, and the results of the few studies have been conducted 
are not fully conclusive. Some randomized controlled trials (RCTs) 
that aimed to prove the efficacy of MCT in improving cognitive 
insight reported different conclusions: MCT improved self-reflec-
tiveness, but not self-certainty (Lam et al., 2015); MCT improved 
self-certainty, but only immediately post-intervention, without af-
fecting self-reflectiveness (Ochoa et al., 2017); or MCT had no sig-
nificant effects (Ishikawa et al., 2020; van Oosterhout et al., 2014). 
In respect to functional improvements, some studies proved the ef-
ficacy of MCT in improving social functioning (Ishikawa et al., 2020; 
Naughton et al., 2012; Ussorio et al., 2016), but another study re-
ported no significant improvements (Gawęda et al., 2015).
MCT can be considered a psychotherapeutic and psycho-educa-
tional intervention that can be applied by mental health and psychi-
atric nurses within the capacity of their specific skillset. This study is 
the first RCT of MCT in schizophrenia assessing a Portuguese popu-
lation. It is also the first study where the MCT was applied by mental 
health and psychiatric nurses working in clinical practice. Given the 
close therapeutic relationship between these nurses and their pa-
tients and the level of trust shared, as nurses are part of the daily 
therapeutic plan with a specific skill set, we believe that these factors 
may contribute to the efficacy of MCT. This is a novel assessment 
that has never been performed in previous studies. Specifically, this 
study intended to test the efficacy of MCT on psychotic symptoms, 
cognitive insight and functioning in patients with schizophrenia.
2  | THE STUDY
2.1 | Aim
The study aimed to evaluate the efficacy of MCT administered in 
a group setting in people with schizophrenia and to determine its 
effects on psychotic symptoms, cognitive insight and functioning.
The hypotheses were as follows:
• Cognitive insight in the MCT group will be better than that in the 
control group at the end of the programme and at follow-up;
• Functionality in the MCT group will be better than that in the con-
trol group at the end of the programme and at follow-up;
• The severity of psychotic symptoms in the MCT group will be 




This study was an RCT.
All procedures followed the CONSORT (Consolidated Standards 
of Reporting Trials) guidelines for the four phases: enrolment, in-
tervention allocation, follow-up and data analysis. The follow-up 
assessment was performed 3 months after the conclusion of the 
MCT programme. The trial has been registered at ClinicalTrials.
gov (ID NCT03891186) and the protocol was published by Pinho 
et al. (2020).
2.2.2 | Participants
The sample was selected by a probabilistic method and participants 
were randomly allocated to one of two groups (experimental or con-
trol). A stratified random sampling method was applied. Participants 
were stratified by educational level, duration since onset of schizo-
phrenia and type of treatment received.
The sample of the study was composed of 56 patients with 
schizophrenia from three psychiatric institutions from Portugal. 
Patient recruitment was based on the following criteria: age between 
18-65 years; diagnosis of schizophrenia as evaluated by a psychiatric 
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assistant; and no changes in antipsychotic medications used within 
4 months before the start of the programme. We excluded patients 
with very severe psychotic symptoms that could have impeded their 
understanding of the objectives of the sessions.
Eligible participants were recruited by the principal investi-
gator in collaboration with a multidisciplinary team from each 
institution between July and September 2019. The study was 
explained to the participants, individually and written informed 
consent was obtained from each. A baseline assessment was 
carried out between August-September of 2019 using the psy-
chometric instruments described below (these included the 
Psychotic Symptoms Rating Scales [PSYRATS], the Personal and 
Social Performance [PSP] scale, the World Health Organization 
Disability Assessment Schedule [WHODAS] and the Beck 
Cognitive Insight Scale [BCIS]).
Participants were randomly allocated to either the MCT group 
(experimental group) or the control group by a multidisciplinary team 
from each institution (Figure 1). The control group did not receive 
MCT. In both groups, treatment as usual (TAU) was maintained. 
All participants were re-assessed at the end of the programme 
(post-treatment timepoint) and 3 months after completion (fol-
low-up timepoint) by the principal investigator, who did not know to 
which group the participants belonged. Plans were in place to apply 
the MCT to the control group after the follow-up.
A practical training course on MCT was conducted in June 2019 
by two researchers of this study with all psychiatric and mental 
F I G U R E  1   CONSORT flow diagram
Assessed for eligibility (N = 422) 
Excluded (n = 366) 
Not meeting inclusion criteria (n = 318) 
Declined to participate (n = 16) 
Not available (n = 32) 
Analysed for intention to treat (n = 27) 
Excluded from analysis (n = 0)
Lost to follow-up (n = 1) 
Discontinued intervention and could not 
complete pre, post and follow up) (n = 1) 
Allocated to MCT + TAU (n = 27) 
Received MCT + TAU (n = 27)
Lost to follow-up (n = 3) 
Discontinued intervention  
could not complete pre, post and follow 
up ) ( n  = 3) 
Allocated to TAU (n = 29) 
Received TAU (n = 29)
Analysed for intention to treat (n = 29) 




Randomized (n = 56) 
Enrollment 
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health nurses who provided the MCT. It was applied in two sessions 
per week for a total of eight sessions between August and October 
2019. MCT was provided face-to-face in a group setting in a quiet 
room.
2.2.3 | Sample size
Sample size calculation was conducted using G*power (Erdfelder 
et al., 1996) based on the theory that small to medium effect sizes 
have been found for improvements associated with MCT (Moritz 
et al., 2013). Effect sizes were calculated using partial η2 values. The 
sample size was previously calculated assuming an effect size like 
those of a previous study (Moritz et al., 2013), with an alpha = 0.05 
and power = 0.80. A total sample size of 36 (18 participants per 
group) was considered to be necessary to detect an effect for the 
primary outcome measure (PSYRATS delusion score) based on the 
partial η2 = 0.04 reported by Moritz et al., 2013, based on a re-
peated-measures ANOVA. We considered a dropout of 10%.
2.2.4 | Study intervention
TAU
All participants continued to receive TAU at the three participating 
institutions. TAU in one of the three institutions was a psychoso-
cial rehabilitation programme for community patients. In the other 
two institutions, patients were in long-term care and participated in 
other rehabilitation activities. All of the participants received treat-
ment from mental health psychiatric nurses, psychiatrists, psycholo-
gists, social workers and occupational therapists. The control group 
did not participate in the MCT programme in this trial.
MCT for psychosis
MCT was first developed by Moritz and collaborators in 2003/2004 
(Moritz & Woodward, 2007; Moritz, Vitzthum, et al., 2010; Moritz, 
Woodward, et al., 2010) and training has been updated since that 
time. The most recent Portuguese update is version 6.3 (Moritz 
et al., 2017). Specific terms were adapted for Portugal, but the exam-
ples were kept the same for consistency across countries. However, 
the exact intervention and examples could be tailored by the thera-
pist to meet specific group needs. This training is currently available 
in 37 languages.
MCT is a therapy developed to treat the positive symptoms of 
psychosis and is composed of eight modules addressing common 
cognitive issues and biases for solving problems in psychosis. The 
topics of MCT include the following: attribution blaming and taking 
credit (Module 1), jumping to conclusions (Modules 2 & 7), changing 
beliefs (Module 3), deficits in theory of mind and social cognition 
(Modules 4 & 6), overconfidence in (memory) errors (Module 5) and 
depression and low self-esteem (Module 8). Each module consisted 
of one session.
Each session aims to convey knowledge about cognitive distor-
tions, such as false memory and overconfidence and to help patients 
reflect critically on their biases and acquire new problem-solving 
strategies. Each session lasted 45–60 min and followed a protocol 
defined in the ‘Metacognitive Training for Psychosis (MCT)’ man-
ual (Moritz et al., 2017). Each module was supported by multimedia 
slides and homework exercises. Other support materials like videos 
could be used.
Each module represents a style of thinking that is recognized as 
contributing to the development of delusions (e.g. distortions in the as-
signment of meanings). Each is presented through examples and exer-
cises and the fallibility of human cognition is discussed and illustrated. 
The therapist also shows participants how exacerbation of thought 
biases can cause problems in daily life, such as increasing the likeli-
hood of delusions. Examples that happen in psychosis are discussed 
and participants are encouraged to share their own experiences. Non-
adaptive coping strategies (e.g. avoidance and suppression of thought) 
are highlighted and suggestions are provided for substitution by adap-
tive strategies. The aim of MCT is to teach participants not to make 
hasty judgments without adequate information and to reflect on their 
own thought patterns. At the end of each session, the therapist gives a 
brochure to the participants with exercises to help them train at home. 
For example in Module 1 (attribution blaming and taking credit) the 
homework gets the participant thinking about a real situation, (e.g. a 
friend missing a meeting) and has them assign various possible causes, 
which are related to the self, others or the situational circumstances.
MCT is an open programme, so patients can join at any time 
during each cycle and if a participant misses a session, no repetition 
is necessary. The MCT is not designed to require the modules to be 
completed sequentially.
A yellow and a red card are handed to group members at the end 
of the first session. The yellow card aims to remind them to recon-
sider the available evidence before making hasty or false decisions, 
which could have momentous consequences. On the red card, the 
individual is asked to list contacts of persons and institutions that 
could be helpful in the event of a crisis. All these materials are avail-
able at www.uke.de/mct.
2.2.5 | Data collection and outcome measures
The psychometric instruments were applied to all participants in the 
study through an interview at each of the three different assessment 
times (before the first session, after the last session [post-treatment] 
and 3 months after the last session [follow-up]) . Sociodemographic 
and clinical data were collected to characterize the sample at baseline 
(age, sex, marital status, cohabitation, educational level, professional/
employment status, duration of mental disorder, number of psychi-
atric hospitalizations, type of treatment and substance use history).
Primary outcome
The PSYRATS (Haddock et al., 1999) are semi-structured interviews 
that provide a detailed measurement of delusions and hallucinations. 
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The PSYRATS consist of 17 items and two subscales: one scale as-
sesses hallucinations (11 items), whereas the other scale assesses 
delusions (6 items). Each item is assessed on a five-point Likert scale 
(range: 0–4). It has been validated for the Portuguese population 
(PSYRATS hallucination subscale, α = 0.96; PSYRATS delusion sub-
scale, α = 0.89; Telles-Correia et al., 2017).
Secondary outcomes
The BCIS (Beck et al., 2004) was administered to evaluate cognitive 
insight through a self-report questionnaire; the scale consists of 15 
items, with two subscales for self-reflectiveness and self-certainty. 
BCIS is in the process of being validated for the Portuguese popula-
tion by the researchers of this study (dimension of self-reflective-
ness, α = 0.70; dimension of self-certainty, α = 0.70).
The WHODAS 2.0 was developed by the WHO to evaluate the 
level of functioning. It consists of 12 items administered as a self-re-
port questionnaire and has been validated for the Portuguese popu-
lation (α = 0.86; Moreira et al., 2015).
The PSP (Morosini, Magliano, Brambilla, Ugolini, & Pioli, 2000) 
was developed to assess patients' social functioning with regards 
to four main areas: socially useful activities, personal and social re-
lationships, self-care and disturbing and aggressive behaviours. It 
has been validated for the Portuguese population (α = 0.79; Brissos 
et al., 2012).
The PSYRATS, BCIS, WHODAS 2.0 and PSP were administered 
to both groups before the first MCT session (baseline) and a week 
after the end of the eight sessions (post-treatment). Three months 
later, these psychometric instruments were re-administered during a 
follow-up evaluation in both groups.
Subjective appraisal of the interventions
At the end of the MCT, an anonymous questionnaire was adminis-
tered to the experimental group to assess the acceptability, feasibil-
ity and subjective efficacy of the interventions. The questionnaire 
closely followed one that was administered in previous trials (Moritz, 
Kerstan, et al., 2011; Moritz, Veckenstedt, et al., 2011; Moritz 
et al., 2013; Moritz & Woodward, 2007). Moritz and Woodward 
(2007) recommend that this scale only be used in a descriptive 
fashion.
2.2.6 | Data analysis
The analyses were conducted by assuming both a per-protocol (PP) 
and an intention to treat (ITT) strategy. The PP analyses considered 
participants who completed the three assessments (pre-treatment, 
post-treatment and follow-up). The ITT analyses considered all par-
ticipants who completed at least the pre-treatment.
A descriptive analysis was used to characterize the sample. Chi-
square tests or unpaired t tests were used for group comparisons of 
sex, age, level of formal education, number of hospitalizations, years 
of disease and type of treatment received. To compare baseline 
characteristics between groups, t tests were used. A mixed-model 
repeated-measures ANOVA was performed to compare treatment 
groups (MCT + TAU vs. TAU) across time (Pre- vs. Post-treatment 
and Pre-treatment vs. Follow-Up). Differences were considered sig-
nificant when p < .05. The data were analysed using IBM Statistical 
Package for the Social Sciences (SPSS®) version 24.0 software for 
Windows.
2.2.7 | Validity and reliability
The study protocol was registered in the Clinical Trials Registry 
Platform and published by the authors (Pinho, et al., 2020). The 
psychometric instruments used have already been validated for 
the Portuguese population. The MCT intervention has been used 
in other countries and the studies have been published. The psy-
chiatric nurses that applied the intervention were properly trained 
beforehand. The same investigator administered the questionnaires 
(LP) at all three timepoints and she had clinical and research expe-
rience in treating and investigating schizophrenia. This researcher 
was blinded and did not know to which groups the participants be-
longed. All data were collected through face-to-face interviews. The 
data collection was conducted at three different institutions and the 
MCT was administered by three different psychiatric nurses, which 
increased the sample representativeness.
2.3 | Ethical considerations
The study was conducted while respecting all ethical principles 
outlined in the Declaration of Helsinki and its subsequent revisions 
(World Medical Association, 2013). Approval was obtained from all 
the institutions' ethics committees. All participants were informed of 
the study's objectives, methodology, benefits and possible risks. All 
patients signed written informed consent forms. Participant confiden-
tiality was maintained throughout all study procedures. Participants 
were informed that they could withdraw their participation at any 
time without penalty. Only members of the research team and health 
professionals who were in charge of the care of the participants had 




Baseline characteristics for demographic and treatment-related data 
were similar across groups (see Table 1). There were slightly more 
men than women (53.6%), with a mean age of 50.55 years (±8.75). 
Participants were mostly single (69.6%). Three out of four partici-
pants had the disorder for more than 20 years and 55.3% were hos-
pitalized more than five times. All the participants were receiving 
antipsychotic medication at the time of baseline assessment.
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3.2 | Outcomes
Based on repeated measures ANOVA and the effect on the primary 
outcome measure (PSYRATS delusion subscale) that had a partial 
η2 = 0.244 post-intervention, we calculated the effect size (0.5681); 
the power of our sample is nearly 1, with 52 participants. Most of 
the participants of the MCT group participated in all eight sessions; 
only eight participants did not (two participated in five sessions; two 
participated in six sessions and four participated in seven sessions).
PP and ITT analyses did not differ (i.e. for all analyses, the level 
of significance (p < .05) remained unchanged). Between-group dif-
ferences are shown in Table 2. For the PSYRATS delusion score, hal-
lucination score and total score and the PSP score, the MCT group 
was superior relative to the control condition at both post-treatment 
follow-up timepoints. For the BCIS self-certainty score and the BCIS 
total score, significant effects were observed in the MCT group rel-
ative to the control group at the 1-week post-treatment timepoint, 
but not at the 3-month follow-up. The observed effect sizes were at 
least medium to large or very large (𝜂2
p
>0.095).
For the PSYRATS delusion score and total score and the PSP 
score, within-group significant effects were observed in the MCT 
group, but not the control group. For the PSYRATS hallucination 
score and the BCIS total score, significant within-group effects were 
observed in the MCT group 1-week post-treatment, but not at the 
3-month follow-up (see Table 2). None of the within-group effects 










Male 14 16 χ2(1) = 0.06 p = .803
Female 13 13
Age 48.30 (9.89) 52.66 (7.14) t (54) = 1.91 p = .062
Formal education 8.07 (2.96) 7.34 (3.98) t (54) = 0.78 p = .438
Treatment-related data
Hospitalizations (including present)
Once 2 2 χ2(3) = 1.94 p = .585
2–5 times 9 12
6–10 times 5 8
>10 times 11 7
Years of disease









Delusion score 9.41 (8.82) 10.86 (8.38) t (54) = −0.63 p = .53
Hallucination 
score
11.04 (13.46) 8.66 (14.43) t (54) = 0.64 p = .53
Total score 20.44 (19.39) 19.52 (18.42) t (54) = 0.18 p = .86
BCIS
Self-reflectiveness 11.11 (5.18) 10.86 (5.93) t (54) = 1.67 p = .87
Self-certainty 8.74 (3.63) 7.31 (3.89) t (54) = 1.42 p = .16
Total score 2.37 (6.39) 3.55 (8.00) t (54) = −0.608 p = .55
PSP 57.19 (10.46) 54.15 (11.01) t (54) = 1.06 p = .30
WHODAS 2.0 21.96 (7.68) 24.86 (5.70) t (54) = −1.61 p = .11
TA B L E  1   Baseline characteristics
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3.3 | Subjective assessment of the training
Most parameters were positively appraised by participants (see 
Table 3). All participants rated the MCT as useful and sensible and 
found it beneficial that the training was administered in a group set-
ting. More than 90% of the participants considered the MCT fun, 
useful to daily life and an important part of their treatment pro-
gramme; they also confirmed that the goals and rationale of the MCT 
were clear to them. In total, 84% of participants would recommend 
the training to others.
4  | DISCUSSION
The current trial was the first to evaluate the efficacy of the MCT 
programme in a Portuguese sample (a prior study employed a mixed 
intervention). Unlike in previous studies where MCT was usually ad-
ministered by psychologists, in this trial, it was applied by mental 
health and psychiatric nurses, which proved to be feasible and, ap-
parently, did not compromise the treatment efficacy.
With respect to MCT efficacy, for the PSYRATS delusion score, 
significant improvements were observed in the MCT group relative 
to the control group, with a high effect size. This is in line with prior 
RCTs that also used PSYRATS assessments (Briki et al., 2014; Favrod 
et al., 2014; Moritz et al., 2013). Delusion scores also decreased in a 
previous study that used individualized MCT (Andreou et al., 2017). 
With respect to the PSYRATS hallucination score, our study only 
found a significant improvement at the post-intervention timepoint 
compared with that at baseline. Another RCT showed similar results 
for the MCT group (Briki et al., 2014). However, in another study that 
used PSYRATS measurements, no significant changes were observed 
in any PSYRATS domains between groups. These non-significant re-
sults may be due to a low severity of psychotic symptoms at baseline in 
the sample (Gawęda et al., 2015). A meta-analysis of RCTs of MCT that 
included calculations of 11 different effect sizes of outcome measures 
immediately post-intervention showed that MCT had a moderate im-
mediate effect on delusions (Liu et al., 2018). In our sample, the effect 
sizes were very large (PP: 2
p
=0.244) post-intervention. With respect 
to the longer-term effects of MCT on delusion at 6 months post-in-
tervention, four effect sizes were analysed in the same meta-analysis, 
with the results showing that MCT had a moderate lasting effect (Liu 
et al., 2018). In our sample, the effect size was also very large (PP: 
2
p
=0.176) at the follow-up timepoint (3 months post-intervention). 
MCT aims to change the cognitive infrastructure of thinking of the 
patients to make them reflect on their cognitive biases, to think about 
their own thought patterns and to start questioning their delusions.
The group MCT programme was also efficacious in improving so-
cial functioning. Based on the PSP scale, significant improvements 
were observed in the MCT group relative to the control group. A 
study that administered a version of the MCT protocol tailored for 
youths also observed similar PSP changes (Ussorio et al., 2016). Other 
studies that used the General Assessment of Functioning (GAF) scale, 
which measures patients' psychological, social and occupational 
functioning, also showed positive improvements in social function-
ing in the MCT group (Ishikawa et al., 2020; Naughton et al., 2012; 
Yildiz et al., 2019). However, another study that used the GAF mea-
sure observed no significant differences between groups, but their 
sample consisted of patients who had severe problems in organizing 
their everyday activities and self-care (Gawęda et al., 2015), which 
may explain the discrepancies. The improvement of social function-
ing in the MCT group may be associated with the improvement of 
positive symptoms, although a previous systematic review identified 
no conclusive relationship between positive symptoms and function-
ing in schizophrenia and more studies are needed (Pinho et al., 2018). 
However, that review only evaluated studies that used the Quality 
of Life Scale (QLS). Moreover, group activity in the MCT sessions 
may have contributed to improving the social functioning of the par-
ticipants; therefore, we consider that group interventions could be 
beneficial in this regard. MCT aims to change thought patterns and 
patients could be more sociable if they are able to decrease their dis-
trust of others and overcome the biases that have an impact on their 
social behaviours (especially attributional style).
For the WHODAS assessments, the results were not significant. 
WHODAS aims to evaluate functioning across all areas of life, not 
just social functioning. Perhaps the lack of positive outcomes is 
related to the fact that people with schizophrenia usually have se-
verely impaired social and occupational functioning, whereas other 
areas of functioning can remain unaffected. In addition, the version 
of the WHODAS used in this study contained only 12 items, whereas 
a longitudinal study of 4,497 patients with schizophrenia that eval-
uated functioning used WHODAS 2.0, which contained 32 items, 
which may explain the discrepancies. The latter study showed that 
the domains of cognition, mobility and participation significantly 
decreased, but the domains of self-care, cooperation and daily life 
TA B L E  3   Subjective assessment of the MCT interventions at 
post-treatment (N = 25)
Yes No
The training was useful and sensible. 25 (100%) 0
I had to force myself to go to the 
training regularly.
8 (32%) 17 (68%)
In everyday life, I do not apply the 
lessons learned.
13 (52%) 12 (48%)
The training was an important part of 
my treatment programme.
23 (92%) 2 (8%)
I would have liked to spend the time 
doing something else.
10 (40%) 15 (60%)
The training was fun. 24 (96%) 1 (4%)
A lot of what I learned during training is 
useful to daily life.
24 (96%) 1 (4%)
The goals and rationale of the training 
were clear to me.
24 (96%) 1 (4%)
I would recommend the training to 
others.
21 (84%) 4 (16%)
I found it beneficial that the training 
was administered in a group.
25 (100%) 0
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activities remained unchanged (Chen et al., 2019). No RCTs were 
found that evaluated the efficacy of MCT using the WHODAS.
With respect to cognitive insight, the self-reflectiveness score 
was not significantly different between groups. Contrary to our trial 
results, another RCT (MCT group + TAU group) conducted in Hong 
Kong of patients with schizophrenia showed significant improvements 
in measures of self-reflectiveness in the MCT group compared with 
the control group (Lam et al., 2015). For the BCIS, our results showed 
significant improvements from baseline at the post-treatment time-
point in the MCT group for total scores and self-certainty scores rel-
ative to the control group, but these results not were maintained at 
the 3-month follow-up assessment. Similar results were obtained in an 
RCT conducted in Spain that assessed a sample of 126 patients with 
a recent onset of psychosis where the participants were randomly as-
signed to either an MCT group or a psycho-educational intervention 
group with cognitive-behavioural elements (Ochoa et al., 2017). Other 
studies also did not observe a significant improvement in cognitive in-
sight in the MCT as evaluated by the BCIS (Ishikawa et al., 2020; van 
Oosterhout et al., 2014). However, a study with a sample of young 
patients with psychosis (18–35 years of age) that applied the youth 
version of the MCT programme showed that this programme was effi-
cacious in improving both components of cognitive insight (self-reflec-
tiveness and self-certainty). The authors conclude that, with respect 
to cognitive mental flexibility, this robust improvement of cognitive 
insight could be associated with the young age of the patients and it 
may be harder to improve cognitive insight in older patients (Ussorio 
et al., 2016). Therefore, based on the results of this and prior studies, 
it remains unclear whether MCT is effective in improving cognitive 
insight. Perhaps this uncertainty can be attributed to the fact that 
cognitive insight is difficult to change and maybe continuous and daily 
training with a longer follow-up time is needed. The self-help smart-
phone app ‘MCT & More’, available from www.uke.de/mct_app, could 
help improve cognitive insight over time.
The subjective assessment indicated that the participants in 
the MCT group were satisfied with the training they received and 
the study had many other strengths, including internally consistent 
methodology, a high completion rate, the administration of an inter-
nationally validated intervention and the involvement of practicing 
psychiatric and mental health nurses of the patients' own institu-
tions, who have acquired skills that will allow them to continue ad-
ministering MCT in the future.
The current trial is the first to administer an eight-session MCT 
programme in a group setting in a Portuguese population. The re-
sults validated the fact that MCT is efficacious in this culture and the 
programme can be successfully conducted by trained nurses to ef-
fectively reduce psychotic symptoms and improve social functioning.
4.1 | Limitations
Some limitations of this trial should be acknowledged. First of all, the 
sample size should have been larger, but this was not possible due to 
the difficulty of assessing the participants. However, our sample size 
did meet the minimum requirements to ensure sufficient power to 
observe a significant effect based on the calculation of the sample 
size described in the Methods. Second, this study was only single-
blind, with only the researcher who applied all the questionnaires 
not knowing the group. While randomization minimizes differences 
between treatment groups at the beginning of the study, it does not 
prevent differential group biases (Karanicolas et al., 2010). Third, the 
TAU in the control group can also be considered a limitation. The 
implementation of a placebo or active control intervention would 
have been superior in this regard. However, all patients continued to 
participate in psychosocial rehabilitation programmes and continued 
to undergo the usual interventions, which may have minimized this 
bias. Fourth, social desirability is also a potential limitation, as partic-
ipants receiving the intervention may have been trying to please the 
providers by responding favourably. To mitigate this limitation, the 
researcher that administered the psychometric assessments was an 
individual external to the institution; this person did not administer 
the MCT intervention. Therefore, the participants only had contact 
with this researcher at the three timepoints when data were col-
lected. Future research should aim to replicate this study with larger 
samples of patients with schizophrenia with different sociodemo-
graphic and clinical characteristics to improve the generalizability of 
our findings.
5  | CONCLUSION
Our results showed that MCT has an antipsychotic effect in patients 
with schizophrenia. MCT applied in a group setting significantly 
reduced delusions and improved social functioning and self-reflec-
tiveness in a Portuguese population. This trial also proved that MCT 
could be successfully administered by psychiatric and mental health 
nurses. Given these results and the benefits of MCT, it should be-
come part of psychosocial rehabilitation programmes for people 
with severe mental illness.
We also recommend that future MCT studies use the self-help 
smartphone app ‘MCT & More’ (available at http://www.uke.de/
mct_app) to understand its effects in helping to complement MCT. 
This app is currently undergoing Portuguese language translation. 
We also recommend comparative studies be conducted with two 
groups. In the first group, MCT should be applied by mental health 
and psychiatric nurses who are part of the daily therapeutic plan; 
the second group should receive MCT by external professionals who 
do not know the patients. In this way, one can test whether having 
a pre-established therapeutic relationship with patients influences 
the efficacy of MCT. Because differential changes in cognitive in-
sight were observed following MCT, we suggest that future trials 
apply MCT in older and younger samples to compare the results be-
tween age groups and the studies should be longitudinal to help un-
derstand how MCT outcomes vary over the course of schizophrenia 
progression.
For clinical practice, we suggest the implementation of MCT 
groups for patients with schizophrenia in rehabilitation programmes 
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as soon as possible after diagnosis, so that they become aware of 
their cognitive biases and begin to train the mind from an early age 
in an attempt to slow the progression of delusions. We also recom-
mend employing family psychoeducation programmes to compli-
ment MCT. Academically, we recommend that MCT be taught in 
the psychiatric and mental health nurses' curricula of this specialty 
master's degree.
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